The Westminster lensArchive · §02 Speeches · 802 contributions

Speeches by Beales.

Every Hansard contribution by Danny Beales this parliament, most recent first. Back to the MP page for the headline figures and analysed positions.

Showing 4160 of 802 contributions · most-recent first

← PreviousPage 3 of 41Next →
DateDebate & contributionWords
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Can you do that in a light-touch model of prescribing, I guess that more sustained engagement and behavioural change, perhaps dealing with some underlying issues that are quite deep-seated and long term? People might have been battling with, as you say, different diet and exercise programmes, mental health issues or pe

77
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Is there a sense that you are underpricing—that you are seeking to present quite a low-cost option, perhaps cutting back some things? I an not saying necessarily that this is what you get if you go straight to your GP, but I think NHS England’s guidance talks about the need for five psychologist sessions. We certainly

113
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

This is perhaps a question for you all. How do you monitor engagement and take-up in the additional services you provide? Are you confident that the videos that you are providing, the consultations, are being utilised by the patient? We have all done online HR mandatory modules, where we click very quickly to get throu

84
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

I think Juniper also mentioned that people are twice as likely to achieve weight loss in the model, to your point, Claire. What evidence do you have about the long-term and sustained impacts of your approaches around weight loss? I guess this is one of the common questions about these interventions with GLP-1. Are you

73
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

If any of those issues come back indicative of potential low risk or high risk or diagnosed conditions, what happens to the patient then?

24
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Kieran and Simon, is there any similarity in additional structured pricing options, depending on the level of support, or is it just one flat price?

25
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Would that lead to additional services that you would provide and charge for or—

14
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

The extra support you provide, is that all benchmarked into the price; there is no additional pricing? Are there additional options you offer to people with varying prices attached?

29
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

How much is that?

4
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

A couple of you have leant upon sexual health services as an example. One of the common complaints in sexual health services is that there is inappropriate testing by private providers that would not be recommended and increased referrals to the NHS through inappropriate tests that are conducted. These could be genetic

126
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

So you just refer back to the NHS to deal with the issues?

13
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

The study and data collection is under way. Do you have any sense—

13
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Good morning. The NICE appraisal talked about the importance of wraparound care associated with the treatments, and the NHS England proposal talked about a number of different appointments that people required. Simon, I think you touched on the number of GP appointments. What does the wraparound care offer look like fo

74
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Is a blood test clinically indicated? Are they recommended as part of the normal treatment pathways?

16
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Is the nutritionist, etc, all included in the cost up front?

11
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Is that one-to-one support or signposted?

6
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Is it standard practice that GPs would be kept informed?

10
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Kieran, Pharmacy2U suggested in its evidence that your sector could provide these services for £300 a year, compared with £1,200 a year. What drives that price differential?

27
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

That is helpful. Are you aware of any instances where the incomplete records or medical records have created any issues around prescribing or complications, or any challenges for any of your patients? Has that been an issue?

37
25 Mar 2026Health and Social Care Committee — Oral Evidence (HC 1181)

Have any of you had data based on what your patients are sharing with you around that behaviour change point? I think that would be very interesting for the Committee to see.

32
← PreviousPage 3 of 41 · click a debate to open the transcript with this MP’s speeches highlightedNext →
Sources
SourceHansard · official report
MethodEach row is one contribution (intervention or speech). Word count from the official text.